Related Experiment Video
Updated: Jun 17, 2026

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
Published on: February 5, 2018
Detecting a Novel NOTCH3 Variant in Patients with Suspected CADASIL: A Single Center Study
Zeynep Selcan Şanli1, Özlem Anlaş2
1Department of Neurology, Adana City Training and Research Hospital, University of Health Sciences, Adana, Turkey.
Insights
Researchers identified a new NOTCH3 gene variant in three patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). This discovery expands the known genetic causes of this familial small vessel disease.
Area of Science:
- Neurology
- Genetics
- Vascular Biology
Background:
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a prevalent adult familial cerebral small vessel disease.
- It is primarily caused by variants in the NOTCH3 gene, presenting with diverse clinical and radiological features.
Purpose of the Study:
- To investigate the clinical, radiological, and genetic variability in patients undergoing NOTCH3 variant analysis.
- To identify and characterize novel genetic variants associated with CADASIL.
Main Methods:
- Comprehensive clinical and neuropsychological assessments.
- Cerebral magnetic resonance imaging (MRI) and Doppler sonography.
- Next-generation sequencing for NOTCH3 gene variant detection.
Main Results:
- A novel heterozygous c.380C>T pathogenic variant in the NOTCH3 gene was identified in three patients.
- This variant leads to a Proline to Leucine substitution at the 127th amino acid position.
- The identified variant is previously unreported.
Conclusions:
- The discovery of this novel NOTCH3 variant expands the known genetic spectrum of CADASIL.
- This finding may facilitate further research into NOTCH3-associated diseases and potential therapeutic strategies.
Introduction:
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common form of familial cerebral small vessel disease in adults and is caused by NOTCH3 variants. Clinical manifestations of CADASIL include recurrent ischemic strokes, dementia, migraine or migraineous headaches, epileptic seizures, and psychiatric disorders. The clinical-radiological phenotype of the disease is also highly variable. In this study, we investigated the variability of clinical, radiological, and genetic data in patients analyzed for NOTCH3 variant in our clinic.
Methods:
We performed clinical and neuropsychological examination, cerebral magnetic resonance imaging (MRI) and Doppler sonography of cerebral arteries in all patients. Next-generation sequencing test was used for detect variants in NOTCH3 gene from all CADASIL patients.
Results:
By using the next-generation sequencing method, heterozygous c.380C>T pathogenic variant was detected in the 4th exon of the NOTCH3 gene in 3 patients. This is a previously unreported novel variant and resulted in the replacement of the amino acid Proline at 127th position with Leucine.
Discussion And Conclusion:
The discovery of this novel pathogenic variant region may contribute to the expansion of the clinical and genetic spectrum of diseases associated with NOTCH3, leading to further research and treatment options for this disease in the future.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Mitral Stenosis II: Clinical features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies